Yahoo
Paris - Delayed Quote EUR

Clariane SE (CLARI.PA)

3.9360 -0.0440 (-1.11%)
As of 12:54:19 PM GMT+2. Market Open.
Chart Range Bar
Loading chart for CLARI.PA
  • Previous Close 3.9800
  • Open 3.9960
  • Bid --
  • Ask --
  • Day's Range 3.9340 - 3.9960
  • 52 Week Range 3.2700 - 4.9060
  • Volume 52,857
  • Avg. Volume 303,664
  • Market Cap (intraday) 1.406B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 131.20
  • EPS (TTM) 0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 21, 2023
  • 1y Target Est 4.88

Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. In addition, it offers medicalized nursing homes and alternative living solutions, such as shared houses, assisted living, and domiciliary care, as well as outpatient consultations and diagnostics, and social care services. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.

www.clariane.com

70,685

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 9/7/2026, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

CLARI.PA
0.05%
CAC 40 (^FCHI)
1.60%

1-Year Return

CLARI.PA
0.56%
CAC 40 (^FCHI)
7.89%

3-Year Return

CLARI.PA
35.05%
CAC 40 (^FCHI)
15.07%

5-Year Return

CLARI.PA
87.32%
CAC 40 (^FCHI)
23.11%

Analyst Insights

View More

Analyst Price Targets

4.60
4.88 Average
3.9360 Current
5.20 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 9/3/2026
  • Market Cap

    1.44B

  • Enterprise Value

    8.37B

  • Trailing P/E

    118.53

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    0.40

  • Enterprise Value/Revenue

    1.56

  • Enterprise Value/EBITDA

    7.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.23%

  • Return on Assets (ttm)

    2.18%

  • Return on Equity (ttm)

    0.67%

  • Revenue (ttm)

    5.35B

  • Net Income Avi to Common (ttm)

    12.57M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.42B

  • Total Debt/Equity (mrq)

    213.12%

  • Levered Free Cash Flow (ttm)

    898.73M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: